American Healthcare REIT to Participate at BofA Securities 2026 Global Real Estate Conference

IRVINE, Calif.--(BUSINESS WIRE)-- American Healthcare REIT, Inc. (NYSE: AHR) (“Company”) announced today that Jeff Hanson, the Company’s Chairman and Chief Executive Officer, Gabe Willhite, the Company’s President and Chief Operating Officer, and Alan Peterson, the Company’s Vice President of Investor Relations & Finance, will participate in a roundtable presentation at BofA Securities Global Real Estate Conference on Tuesday, September 15, 2026, at 12:45 p.m. to 1:20 p.m. Eastern Time. A live webcast of the presentation will be available at the following link. A replay will be available at the same link following the completion of the conference on September 16, 2026 for up to one year.

The Company will issue its investor presentation on Monday, September 14, 2026, before market open, which can be found at: ir.americanhealthcarereit.com/events-and-presentations/.

About American Healthcare REIT, Inc.

American Healthcare REIT, Inc. (NYSE: AHR) is a real estate investment trust that acquires, owns and operates a diversified portfolio of clinical healthcare real estate, focusing primarily on senior housing communities, skilled nursing facilities, and outpatient medical buildings across the United States, the United Kingdom and the Isle of Man.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260911668696/en/

Investor Contact:
Alan Peterson
VP, Investor Relations & Finance
(949) 270-9200
[email protected]

Media Contact:
Damon Elder
Spotlight Marketing Communications
(949) 427-1377
[email protected]

Source: American Healthcare REIT, Inc.

You May Also Be Interested In

• Semtech Enables 50G Optical Transition for AI-Driven 5G-Advanced
• Strongest Half-Year in Curatis’s History — Revenue up 51% and Significant Progress on Corticorelin (C-PTBE-01)
• C2N Diagnostics Expands Global Partnerships in United Kingdom on World Alzheimer’s Day, Joins Cambridge Cognition and The Alzheimer's Trust to Improve Alzheimer's Disease Diagnosis